Description
The super lean T2 40mg + super lean R3 20mg Blend represents an exciting area of next-generation weight-management research, bringing together two powerful multi-receptor compounds in one formulation. With super lean T2 targeting GIP and GLP-1 receptors and super lean R3 additionally targeting the glucagon receptor, this combination offers researchers an opportunity to investigate complementary pathways involved in appetite, metabolism, energy expenditure and body-weight regulation. With incretin-based therapies already transforming obesity research, this dual-compound approach could represent an important next step in exploring the science behind future weight-management strategies.
FOR RESEARCH PURPOSES ONLY — NOT FOR HUMAN CONSUMPTION
